Home LiteratureArticle Details
PMID: 8842452 Published · ppublish English Clinical Trial Journal Article

Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation.

British journal of pharmacology ·Vol. 118 ·No. 7 ·1996-08-00 ·Pages 1841-7

Fricker G, Drewe J, Huwyler J, Gutmann H, Beglinger C

Abstract

1. The interaction of cyclosporin A (CyA) with p-glycoprotein during intestinal uptake was investigated by a combination of in vitro experiments with human Caco-2 cells and an intubation study in healthy volunteers. 2. CyA uptake into the cells was not saturable and exhibited only a low temperature sensitivity, suggesting passive diffusion. When the permeation of CyA across Caco-2 monolayers from the apical to the basolateral side was determined, overall transport had an apparently saturable component up to a concentration of 1 microM. At higher concentrations permeation increased over-proportionally. Calculation of the kinetic parameters of apical to basolateral permeation suggested a diffusional process with a KD of 0.5 microliter min-1 per filter, which was overlayed by an active system in basolateral to apical direction with a KM of 3.8 microM and a Jmax of 6.5 picomol min-1 per filter. 3. CyA permeation was significantly higher when the drug was given from the basolateral side as compared to the permeation from the apical side. Apical to basolateral transport of CyA was increased in the presence of vinblastine, daunomycin and a non-immunosuppressive CyA-derivative. All compounds inhibit p-glycoprotein-mediated transport processes. Basolateral to apical permeation of CyA showed a dose-dependent decrease in the presence of vinblastine. Permeation of daunomycin across Caco-2 cell monolayers was also higher from the basolateral to the apical side than vice versa. Basolateral to apical permeation was decreased in the presence of SDZ PSC 833 and cyclosporin A. 4. Western blot analysis of Caco-2 cells with the monoclonal antibody C219 confirmed the presence of p-glycoprotein in the used cell system. 5. When the absorption of CyA in the gastrointestinal (GI)-tract of healthy volunteers was determined, a remarkable decrease of the plasma AUC could be observed dependent on the location of absorption in the rank order stomach > jejunum/ileum > colon. The decrease in absorption exhibited a marked correlation (r = 0.994) to the expression of mRNA for p-glycoprotein over the GI-tract (stomach < jejunum < colon). 6. All data provide evidence that CyA is a substrate of p-glycoprotein in the GI-tract, which might explain the local differences and the high variability in cyclosporin absorption found in vivo.

MeSH Terms
ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism,pharmacology Adult Alkaline Phosphatase/metabolism Antibiotics, Antineoplastic/metabolism Area Under Curve Blotting, Western Caco-2 Cells Cyclosporine/administration & dosage,pharmacokinetics Daunorubicin/metabolism Humans Immunohistochemistry Immunosuppressive Agents/administration & dosage,pharmacokinetics Intestinal Absorption/drug effects Intubation, Gastrointestinal Male Middle Aged
Chemicals
ATP Binding Cassette Transporter, Subfamily B, Member 1 Antibiotics, Antineoplastic Immunosuppressive Agents Cyclosporine Alkaline Phosphatase Daunorubicin
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Fricker G
Institute of Pharmaceutics and Biopharmacy, Heidelberg, Germany.
Drewe J
Huwyler J
Gutmann H
Beglinger C
References (35)
35 references, click to expand
  1. Energy-dependent transport of digoxin across renal tubular cell monolayers (LLC-PK1).
    Can J Physiol Pharmacol. 1993 Jan;71(1):40-7 PMID: 8099844
  2. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators.
    J Biol Chem. 1993 Jul 15;268(20):14991-7 PMID: 8100817
  3. Clinical trials of modulation of multidrug resistance. Pharmacokinetic and pharmacodynamic considerations.
    Cancer. 1993 Dec 1;72(11 Suppl):3502-14 PMID: 7902206
  4. Transport of celiprolol across human intestinal epithelial (Caco-2) cells: mediation of secretion by multiple transporters including P-glycoprotein.
    Br J Pharmacol. 1993 Nov;110(3):1009-16 PMID: 7905337
  5. Dose dependent absorption and linear disposition of cyclosporin A in rat.
    Biopharm Drug Dispos. 1994 Jan;15(1):75-86 PMID: 8161718
  6. Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH.
    Cancer Chemother Pharmacol. 1994;34(2):125-32 PMID: 7910786
  7. Effect of the nonimmunosuppressive cyclosporin analog SDZ PSC-833 on colchicine and doxorubicin biliary secretion by the rat in vivo.
    Cancer Chemother Pharmacol. 1994;34(2):133-6 PMID: 7910787
  8. In vivo evidence for ATP-dependent and P-glycoprotein-mediated transport of cyclosporin A at the blood-brain barrier.
    Biochem Pharmacol. 1994 Nov 16;48(10):1989-92 PMID: 7986214
  9. P-glycoprotein-mediated secretion of a fluorescent cyclosporin analogue by teleost renal proximal tubules.
    Am J Physiol. 1995 Jan;268(1 Pt 2):F46-52 PMID: 7840247
  10. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
    Anal Biochem. 1976 May 7;72:248-54 PMID: 942051
  11. Biological effects of cyclosporin A: a new antilymphocytic agent.
    Agents Actions. 1976 Jul;6(4):468-75 PMID: 8969
  12. Cyclosporin A in patients receiving renal allografts from cadaver donors.
    Lancet. 1978 Dec 23-30;2(8104-5):1323-7 PMID: 82836
  13. Studies of relationship among bile flow, liver plasma membrane NaK-ATPase, and membrane microviscosity in the rat.
    J Clin Invest. 1979 Dec;64(6):1590-8 PMID: 227937
  14. Apparent dose-dependent oral absorption of cyclosporin A in rats.
    Biopharm Drug Dispos. 1984 Apr-Jun;5(2):141-51 PMID: 6743782
  15. Cyclosporine: a new immunosuppressive agent for organ transplantation.
    Ann Intern Med. 1984 Nov;101(5):667-82 PMID: 6385799
  16. Cyclosporine.
    Drug Intell Clin Pharm. 1985 Feb;19(2):90-100 PMID: 3882378
  17. Pharmacokinetic profiles of cyclosporine in rats. Influence of route of administration and dosage.
    Transplantation. 1985 Nov;40(5):489-93 PMID: 3877356
  18. Pharmacokinetics and monitoring of cyclosporine following orthotopic liver transplantation.
    Semin Liver Dis. 1985 Nov;5(4):357-68 PMID: 3909430
  19. Expression of a multidrug-resistance gene in human tumors and tissues.
    Proc Natl Acad Sci U S A. 1987 Jan;84(1):265-9 PMID: 2432605
  20. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.
    Proc Natl Acad Sci U S A. 1987 Nov;84(21):7735-8 PMID: 2444983
  21. Specific 3H radioimmunoassay with a monoclonal antibody for monitoring cyclosporine in blood.
    Clin Chem. 1988 Feb;34(2):257-60 PMID: 3277744
  22. Photoaffinity labeling of membrane proteins from rat liver and pig kidney with cyclosporine diazirine. Involvement of binding to plasma membranes cytotoxic effects.
    Transplantation. 1988 Aug;46(2 Suppl):15S-20S PMID: 3406980
  23. Effect of bile on cyclosporin absorption in liver transplant patients.
    Br J Clin Pharmacol. 1988 May;25(5):579-84 PMID: 3044424
  24. Intraindividual variability in the relative systemic availability of cyclosporin after oral dosing.
    Eur J Clin Pharmacol. 1988;34(5):461-4 PMID: 3203705
  25. Cyclosporine.
    N Engl J Med. 1989 Dec 21;321(25):1725-38 PMID: 2687689
  26. The use of cultured epithelial and endothelial cells for drug transport and metabolism studies.
    Pharm Res. 1990 May;7(5):435-51 PMID: 2195492
  27. Transport of bile acids in a human intestinal epithelial cell line, Caco-2.
    Biochim Biophys Acta. 1990 Jul 20;1035(1):97-103 PMID: 2383583
  28. Transport of a large neutral amino acid (phenylalanine) in a human intestinal epithelial cell line: Caco-2.
    Biochim Biophys Acta. 1990 Sep 21;1028(1):25-30 PMID: 2207118
  29. Active absorption of conjugated bile acids in vivo. Kinetic parameters and molecular specificity of the ileal transport system in the rat.
    Gastroenterology. 1991 Jan;100(1):212-21 PMID: 1983823
  30. In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833.
    Cancer Res. 1991 Aug 15;51(16):4226-33 PMID: 1678313
  31. Cyclosporin metabolism by human gastrointestinal mucosal microsomes.
    Br J Clin Pharmacol. 1992 Jun;33(6):661-4 PMID: 1389941
  32. Cyclosporin A metabolism in human liver, kidney, and intestine slices. Comparison to rat and dog slices and human cell lines.
    Drug Metab Dispos. 1992 Nov-Dec;20(6):802-9 PMID: 1362930
  33. Cortisol is transported by the multidrug resistance gene product P-glycoprotein.
    Br J Cancer. 1993 Feb;67(2):284-9 PMID: 8094292
  34. Human P-glycoprotein transports cyclosporin A and FK506.
    J Biol Chem. 1993 Mar 25;268(9):6077-80 PMID: 7681059
  35. Inhibition of the multidrug efflux pump in isolated hepatocyte couplets by immunosuppressants FK506 and cyclosporine.
    Transplantation. 1993 Mar;55(3):646-50 PMID: 7681229
Article Info
Journal
British journal of pharmacology
Abbr.
Br J Pharmacol
ISSN
0007-1188
Published
1996-08-00
Pages
1841-7
Language
English
Region
England
NLM ID
7502536
PMCID
PMC1909843
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]